Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Fibrosis; Scleroderma, Diffuse; Scleroderma, Systemic; Sclerosis Phase 2 ClinicalTrials
CONTENTS